the Joshua Schall Audio Experience

Welcome to the Joshua Schall Audio ExperienceOn my podcast, you’ll hear episodes of my popular short-form Consumer Packaged Goods (CPG) news segment "Consumed", a long-form CPG entrepreneurship interview segment "Formula For:", deeper dive segments "Deep Dish CPG", public speaking engagements, and any of my new and current thoughts that I record specifically for this audio experience!Leave a review on iTunes and let me know what you think!

the Joshua Schall Audio Experience is a business podcast hosted by Joshua Schall, with 842 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Joshua Schall hosts the Joshua Schall Audio Experience, a business show with 842 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  the Joshua Schall Audio Experience

  Why Jamieson Wellness Was Just Acquired for $1.4B By Kirin Holdings

  Aug 18, 202611 min

  Why is one of the world's largest legacy beer companies quietly buying up the global dietary supplement market? In this video, I'm breaking down the radical corporate transformation of Kirin Holdings. Facing a terminal decline in Japan’s domestic beer market due to an aging population, Kirin is executing a masterful multibillion-dollar M&A playbook to pivot heavily into preventative health and functional ingredients. Discover how Kirin built its global "Health Science Triad" by acquiring dominant regional anchors like Blackmores, FANCL, and most recently, Jamieson Wellness for $1.4 billion. I'll dive into their 4-pillar corporate M&A blueprint, how they avoid rigid bureaucracy, and how they use consumer brands as a pipeline for their proprietary, high-margin ingredients like Cognizin and IMMUSE. Lastly, I'll explore if functional beverages and functional foods could be next, along with a future European expansion that would Kirin past their $3 billion Kirin Health Science International segment revenue goal by 2035? Let's get into the strategy.

  ListenShow Notes
• 

  the Joshua Schall Audio Experience

  [MONDAY MINUTE] THEY Finally Admitted Food Prices Are Out Of Control

  Aug 17, 20261 min

  Has the government finally admitted that feeling like you need a second mortgage just to afford the fancy cheese isn’t a vibe? Although instead of sending you a coupon, they’re launching the “Grocery Guarantee,” a strategic "risk-shifter" designed to crack the credit bottleneck for the U.S. food supply chain. By boosting federal loan guarantees, the U.S. Small Business Administration is effectively daring local banks to say "yes" to small producers, manufacturers, grocers, and associated support layers who were previously deemed too risky. And this isn’t some handout…we’re talking about a “modernization play” with 25-year terms for newer technology, smarter equipment, and bigger facilities. So, what’s the catch? While the “Grocery Guarantee” bridges the collateral gap, it doesn't erase today’s high-interest rate environment. If your small business is already underwater, a bigger debt might just be a heavier anchor. Therefore, this program will be most effective for businesses actively pivoting from "survival mode" to "expansion mode."

  ListenShow Notes
• 

  the Joshua Schall Audio Experience

  SILLY Strategic Mistake Ruining MusclePharm | Dr. Tobias & Joey Chestnut | FitLife Brands Q2 2026 Update

  Aug 14, 202613 min

  FitLife Brands just dropped its Q2 2026 earnings report, showing a massive 65% year-over-year revenue spike to $26.5 million. But behind that explosive headline number lies a much more complicated story of acquisition padding, falling legacy brand sales, and major strategic hurdles. Does FitLife Brands need a "strategic cleanse" to restore true balance? In this comprehensive breakdown, I'll dig deep past the surface-level numbers of the FitLife Brands portfolio. Based on Q2 2026 financial documents and my exclusive notes from the earnings call, I'm analyzing exactly how the company is performing after its massive August 2025 acquisition of Irwin Naturals. I divide the portfolio into Legacy FitLife and Irwin Naturals to uncover the real operational health of the business. While consolidated growth looks stellar on paper due to M&A activity, a sequential quarter-over-quarter growth rate of just 4.8% tells a very different story. Key Topics Covered: Sales Channel Shift: How FitLife has successfully lowered its historic "key customer risk" with retail giant GNC, moving from a digital-first strategy back into heavy wholesale distribution. Legacy FitLife Troubles: Why Legacy FitLife segment revenue plummeted 23% YoY, and how company leadership is using "muddy waters" to obscure individual brand declines. Amazon Algorithm Slump: A look into Mimi's Rock Corporation's low-20s percent YoY decline and FitLife’s unexpected partnership with competitive eating champion Joey Chestnut to drive off-Amazon awareness. MusclePharm Misstep: Why attempting to aggressively raise prices on MusclePharm whey protein products backfired, leaving them highly exposed to inflationary commodity cycles without true brand pricing power. Irwin Naturals Silver Lining: Breaking down Irwin’s $14.1 million quarter, its rapid 35% sequential expansion into e-commerce, and whether upcoming cost-saving synergies can rescue FitLife's dilutive profit margins. If you are a CPG industry professional, retail investor, or supplement brand builder, this deep dive into functional CPG market dynamics and execution strategy is a must-watch!

  ListenShow Notes
• 

  the Joshua Schall Audio Experience

  Why Everyone Will Take Creatine | Future of the Creatine Market | "Creatinification" | Steve Jennings (Jenerise)

  Aug 13, 20261h 25m

  “One day, everyone will take creatine.” Maybe that sounds crazy to you. Or maybe you’re like me and more recently came to that conclusion. But for a very (very) small group of people, that bold visionary prediction became obvious more than three decades ago. Joining us is industry pioneer Steve Jennings, one of those rare individuals…who famously helped fuel British Olympic gold medalists with creatine in secret during the 1992 Barcelona games. In this episode, we explore the enormous structural shift driving creatine from “gym culture” to household staple. However, crossing the chasm towards the mainstream brings substantial friction. Therefore, we shed light on the serious risks of a market (potentially) growing too fast, from severe supply chain vulnerabilities and concentrated chemical precursor sourcing to an imminent pricing squeeze on raw materials (which might ultimately be a good thing as Steve outlines). Furthermore, driven by a surge in consumer demand for convenient, great-tasting formats…we discuss how "Creatinification" (and the category’s defining decade ahead) hinges on solving a fundamental biochemical challenge that has long eluded the supplement industry. Tune in as we discuss how the sector is engineering around this stability barrier, tackling immense demand growth, and unlocking preventative health solutions to build a creatine market poised to reach every consumer, everywhere. But without any further delay…here is the recent conversation I had with my good friend and the founder of Jenerise (a creatine technology company) Steve Jennings.

  ListenShow Notes
• 

  the Joshua Schall Audio Experience

  Why P&G Just Acquired Thorne for $3.8 Billion | Will Procter & Gamble Dilute Thorne Supplements?

  Aug 10, 202612 min

  Procter & Gamble just dropped a staggering $3.8 billion to acquire Thorne, leaving mainstream financial commentators and health enthusiasts completely shocked. Why would a consumer packaged goods (CPG) titan known for Pampers, Tide, and Crest buy a premium dietary supplement brand? In this video, I'll pull back the curtain on the financial architecture and the radical corporate strategy driving this massive M&A transaction. This is far from just selling vitamins...creating a massive strategic paradigm shift into AI-powered predictive health, longevity, and data-rich consumer ecosystems. I'm breaking down the private equity wins for L Catterton, Thorne’s massive manufacturing and testing moats, and how P&G completely outmaneuvered rivals like Unilever and Haleon to dominate the healthcare practitioner market. Plus, we address the biggest question on every consumer's mind: Will P&G dilute Thorne's ingredients and destroy its scientific integrity? If you want to understand the future of proactive, personalized, and integrative consumer healthcare, this deep dive is for you.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.